Ultragenyx Pharmaceutical Inc. sell StockNews.com
Start price
29.11.23
/
50%
€35.60
Target price
29.11.24
-
Performance (%)
6.74%
Price
13.05.24
€38.00
Summary
This prediction is currently active. With a performance of 6.74%, the SELL prediction by StockNews_com for Ultragenyx Pharmaceutical Inc. is trending in the wrong direction This prediction currently runs until 29.11.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -5.000% | -5.000% |
| iShares Core DAX® | 2.749% | 4.620% |
| iShares Nasdaq 100 | 0.470% | -0.331% |
| iShares Nikkei 225® | -2.930% | -5.556% |
| iShares S&P 500 | 0.679% | 0.631% |
Comments by StockNews_com for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for RARE provided by MarketBeat